Brivaracetam
NDC 0121-1075, Brivaracetam Injection, injection, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-1075
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218249
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIVARACETAM50 mg/5mL
Pharmacologic classes
Epoxide Hydrolase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-1075-02 | 00121107502 | 10 VIAL, GLASS in 1 CARTON (0121-1075-02) / 5 mL in 1 VIAL, GLASS (0121-1075-55) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5bc0f4c0-8b31-4622-849f-d902be93788b
Use it
Look up 0121-1075 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1075 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-1075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.